Katelyn Peters has a writer and editor for more than five years who focuses on both investing and personal finance content. In addition to her experience in finance, she is also a volunteer editorial ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

Vaadin, the leading provider of Java web application frameworks, today announced the general availability of Swing Modernization Toolkit, a solution that enables organizations to run their existing ...

After several weeks of testing, Apple today released Xcode 26.3, an update that allows developers to use tools like Anthropic ...

Helical IT Solutions launches Helical Insight 6.1, enhancing unified embeddable open-source BI with paginated canned ...

No deposit bonus codes can unlock free rewards without you having to invest any real money. These offers provide great value and can be the start of your casino bankroll. From free spins to bonus cash ...

Our stories are reviewed by medical professionals to ensure you get the most accurate and useful information about your health and wellness. For more information, visit our medical review board. This ...

TSSLint 3, the lightweight TypeScript linting tool by Johnson Chu, enhances performance with a reduced dependencies and improved migration paths from legacy linters. As a spiritual successor to TSLint ...

Taylor Medine is a staff writer for Forbes Advisor with over 10 years of experience writing guides and articles that demystify personal finance topics, such as how to repay debt, build credit and ...

Enterprises seeking to make good on the promise of agentic AI will need a platform for building, wrangling, and monitoring AI agents in purposeful workflows. In this quickly evolving space, myriad ...

Elizabeth Blessing is a financial writer and editor specializing in growth investing, high-yield stocks, small caps, and gold investing. Thomas J. Brock is a CFA and CPA with more than 20 years of ...

Enliven Therapeutics Inc. (Nasdaq: ELVN) reported this week that as of the end of 2025, the clinical-stage precision oncology company has $462.6 million in cash and equivalents, enough runway to fund ...